Tokyo, Dec. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060165) titled 'Development and Validation of the Japanese Version of the Dementia Prevention Awareness Test Based on the Health Belief Model' on Dec. 23.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Healthy older adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to develop a Japanese version of the MCLHB-DRR (Motivation to Change Lifestyle and Health Behaviors for Dementia Risk Reduction) scale, originally developed in English, and to verify its reliability and validity among healthy community-dwelling older adults in Japan.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 40
years-old
Gender - Male and Female
Key inclusion criteria - 1. Middle-aged and older adults aged 40 to 80 at the time of informed consent, who volunteered to participate in the study through Cross Marketing Inc., a survey research firm. (Participants will be recruited in numbers that align with the age and gender distribution ratios of the 2023 Japanese census.)
2. Individuals residing in Japan who are proficient in Japanese.
Key exclusion criteria - 1. Those with complications or disabilities (e.g., psychiatric symptoms or physical impairments) that could interfere with the completion of the questionnaire survey used in this study.
2. Those deemed ineligible by the principal investigator or sub-investigators for any other reason.
Target Size - 500
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2024 Year 10 Month 01 Day
Date of IRB - 2024 Year 10 Month 29 Day
Anticipated trial start date - 2024 Year 10 Month 29 Day
Last follow-up date - 2025 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068811
Disclaimer: Curated by HT Syndication.
